|
|
||||||||
Original Research Communication |
1 From the Lipid Clinic (ÅLA and LO) and the MSD Cardiovascular Research Center (MSN), National Hospital, Oslo, and the Unilever Health Institute, Unilever Research, Vlaardingen, Netherlands (FYN).
Background: Naturally occurring plant sterol esters (SEs) favorably affect serum cholesterol concentrations in humans and could aid in the treatment of children with familial hypercholesterolemia (FH).
Objective: We studied the effect of SE-enriched spread on serum lipids, lipoproteins, carotenoids, fat-soluble vitamins, and physiologic variables in children with FH aged 712 y.
Design: In a randomized, double-blind crossover study comprising two 8-wk interventions, 38 children with FH consumed 18.2 ± 1.5 g SE spread/d, corresponding to 1.60 ± 0.13 g SEs, or a control spread. Blood samples were analyzed at the start and end of each diet period.
Results: Plasma LDL-cholesterol concentrations decreased by 10.2% (P = 0.003) during the SE period compared with the control period. Total cholesterol and apolipoprotein B concentrations were reduced by 7.4% (P = 0.007 and P = 0.020, respectively) during the SE period. No changes were observed in HDL cholesterol, triacylglycerol, or apolipoprotein A-I. Serum concentration of lipid-adjusted lycopene decreased by 8.1% (P = 0.015) in the SE period, with no changes in the other carotenoids. Lipid-adjusted retinol and
-tocopherol concentrations increased by 15.6% (P < 0.001) and 7.1% (P = 0.027), respectively. There was an increase (16.8%, P = 0.04) in alanine transaminase in the SE period, but this was explained by a significantly lower starting concentration in the SE period than in the control period. The children consumed a recommended American Heart Association Step I diet during both intervention periods.
Conclusion: A daily intake of 1.6 g SEs induces an additional reduction in LDL-cholesterol concentrations in children with FH consuming a recommended diet.
Key Words: Plant sterol ester plant sterol supplement sitosterol ester familial hypercholesterolemia serum cholesterol children LDL cholesterol
This article has been cited by other articles:
![]() |
E. M. Haney, L. H. Huffman, C. Bougatsos, M. Freeman, R. D. Steiner, and H. D. Nelson Screening and Treatment for Lipid Disorders in Children and Adolescents: Systematic Evidence Review for the US Preventive Services Task Force Pediatrics, July 1, 2007; 120(1): e189 - e214. [Abstract] [Full Text] [PDF] |
||||
![]() |
US Preventive Services Task Force Screening for Lipid Disorders in Children: US Preventive Services Task Force Recommendation Statement Pediatrics, July 1, 2007; 120(1): e215 - e219. [Full Text] [PDF] |
||||
![]() |
K. G. Moruisi, W. Oosthuizen, and A. M. Opperman Phytosterols/Stanols lower cholesterol concentrations in familial hypercholesterolemic subjects: a systematic review with meta-analysis. J. Am. Coll. Nutr., February 1, 2006; 25(1): 41 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A Castro, L. P Barroso, and P. Sinnecker Functional foods for coronary heart disease risk reduction: a meta-analysis using a multivariate approach Am. J. Clinical Nutrition, July 1, 2005; 82(1): 32 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hedman, T. Matikainen, A. Fohr, M. Lappi, S. Piippo, M. Nuutinen, and M. Antikainen Efficacy and Safety of Pravastatin in Children and Adolescents with Heterozygous Familial Hypercholesterolemia: A Prospective Clinical Follow-Up Study J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 1942 - 1952. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Kreisberg and A. Oberman Medical Management of Hyperlipidemia/Dyslipidemia J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2445 - 2461. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |